Publicaciones en colaboración con investigadores/as de Universidad CEU San Pablo (11)

2023

  1. Diseño de formulaciones para terapia combinada frente alglioblastoma

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2021

  1. A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 193

2018

  1. Effects of an acute exercise bout on serum hepcidin levels

    Nutrients, Vol. 10, Núm. 2

2014

  1. Equidad y desigualdad nutricional en dos centros escolares de la ciudad de Madrid (España)

    Nutricion Hospitalaria, Vol. 29, Núm. 1, pp. 128-135

2006

  1. Calidad de los estudios postautorización de tipo observacional registrados en España antes de su regulación

    Medicina Clinica, Vol. 126, Núm. 16, pp. 607-610

2004

  1. ET-18-OCH3 (edelfosine): A selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor

    Current Medicinal Chemistry, Vol. 11, Núm. 24, pp. 3163-3184

  2. Structural basis for the binding of didemnins to human elongation factor eEF1A and rationale for the potent antitumor activity of these marine natural products

    Journal of Medicinal Chemistry, Vol. 47, Núm. 18, pp. 4439-4452

1999

  1. Novel DNA intercalators based on the pyridazino[1',6':1,2]pyrido[4,3- b]indol-5-inium system

    Journal of Organic Chemistry, Vol. 64, Núm. 11, pp. 3907-3915

1997

  1. Assessment of solvation effects on calculated binding affinity differences: Trypsin inhibition by flavonoids as a model system for congeneric series

    Journal of Medicinal Chemistry, Vol. 40, Núm. 25, pp. 4136-4145

  2. Structure-affinity relationships for the binding of actinomycin D to DNA

    Journal of Computer-Aided Molecular Design, Vol. 11, Núm. 2, pp. 114-128

1996

  1. Molecular dynamics simulations of the bis-intercalated complexes of ditercalinium and Flexi-Di with the hexanucleotide d(GCGCGC)2: Theoretical analysis of the interaction and rationale for the sequence binding specificity

    Journal of Medicinal Chemistry, Vol. 39, Núm. 24, pp. 4810-4824